Terminated: Minrad International Ends Agreement with RxElite
Minrad International has terminated its distribution agreement with RxElite. The action was taken after the RxElite failed to pay $5.6 […]
Read more »Mike Landess’ Battle with Prostate Cancer
A quick shout to Mike Landess, a Denver, CO newsman who this week released a half hour DVD special on […]
Read more »[Video Profile] Interview with Michael Fons, VP Corporate Development at Inovio Biomedical
Inovio Biomedical’s electroporation technology uses brief, controlled electrical pulses to increase cellular uptake of gene expression in DNA-based treatments; this […]
Read more »AngioDynamics: Irreversible Electroporation Shows Early Promise
AngioDynamics announced the first percutaneous use of NanoKnife, an irreversible electroporation (IRE) device. Although its too early to estimate the […]
Read more »Trod Medical: FDA 510(k) Clearance for Encage
Trod Medical has received FDA 510(k) clearance for Encage, a minimally invasive technology for soft tissue ablation. The surgical system […]
Read more »Liquidity Crisis: Minrad International Slashes Jobs, Evaluates Options
In an effort to improve its cost structure and conserve cash, Minrad International said it would layoff 35 percent of […]
Read more »SyntheMed: FDA Clearance for SinusShield
SyntheMed, of Iselin, NJ, has received FDA 510(k) clearance for SinusShield, a bioresorbable membrane to prevent post-operative adhesions from forming […]
Read more »Candela Buys Some Time
Shares of Candela Corporation, a maker of aesthetic lasers, jumped 31% yesterday after the U.S. District Court agreed to postpone […]
Read more »OneMedForum 2009: Finance Conference for Emerging Med Tech Companies
The OneMedPlace finance conference for emerging med tech companies, the OneMedForum, will be held January 13-14 in San Francisco. Click […]
Read more »Escalon: Expansion Efforts Impact Gross Margins
Escalon Medical managed solid revenue growth its first fiscal quarter of 2009. The company reported quarterly revenues of $8.7 million, […]
Read more »